Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5

Rhea-AI Summary

Autolus Therapeutics plc (Nasdaq: AUTL) will report its Q1 2022 financial results and operational highlights on May 5, 2022, before U.S. markets open. A conference call and webcast will follow at 8:30 am ET/1:30 pm BST for management to discuss the results and provide a business update. Investors can access the presentation and call via Autolus' website or by dialing provided numbers for U.S. and international listeners. The call will be available for replay for one week.

Positive

• Upcoming Q1 2022 financial results release expected to provide insights into operational progress.

Negative

• None.

News Market Reaction – AUTL

+2.92%

+2.92% Session move

In the trading session that priced this news, AUTL gained 2.92%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, April 25, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2022 financial results and operational highlights before open of U.S. markets on Thursday, May 5, 2022.

Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website.

The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 3245616. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 3245616.

Contact:

Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com

FAQ

When will Autolus Therapeutics release its Q1 2022 financial results?

Autolus Therapeutics will release its Q1 2022 financial results on May 5, 2022.

What time is the Autolus conference call for Q1 2022 results?

The conference call will be held at 8:30 am ET on May 5, 2022.

How can I access the Autolus Q1 2022 financial results webcast?

You can access the webcast through the events section of Autolus' website.

Will there be a replay of the Autolus Q1 2022 financial results call?

Yes, a replay of the call will be available for one week after the event.